I know this doesn't help older holders but PYC is already worth more than in 2011. Back then the market cap at 5c was under 20m and today it is 30m.
They were GFC affected days and time has passed and deals fallen by the wayside and progress made on others.
The weird thing about the ASX is that small illiquid companies are often ignored so PYC has a better chance of rallying with tightly held shares but plenty of them than when it was a smaller ignored stock.
I'm not saying it has been noticed but it seems like a few are watching and now realising the only way to get involved is to buy on market.
A valuation of 3-5c still seems about right to me for where the company is at so we are just about there - technically it looks good but volume is pretty light so not sure how sustainable it is.
I think this has the potential to stun people with how far it could rally but that's not my central call - just 3-5c pre Janssen update.
- Forums
- ASX - By Stock
- options
PYC
pyc therapeutics limited
Add to My Watchlist
3.03%
!
$1.28

I know this doesn't help older holders but PYC is already worth...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.28 |
Change
-0.040(3.03%) |
Mkt cap ! $746.5M |
Open | High | Low | Value | Volume |
$1.32 | $1.35 | $1.28 | $764.7K | 579.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | $1.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.30 | 40248 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | 1.275 |
1 | 13987 | 1.265 |
2 | 16060 | 1.260 |
1 | 12000 | 1.255 |
2 | 2800 | 1.250 |
Price($) | Vol. | No. |
---|---|---|
1.300 | 40248 | 3 |
1.330 | 5000 | 1 |
1.345 | 53113 | 2 |
1.350 | 22000 | 2 |
1.360 | 5958 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online